Literature DB >> 26202399

Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients.

Junliang Fu1, Ji-Yuan Zhang1, Fu-Sheng Wang2.   

Abstract

Entities:  

Year:  2013        PMID： 26202399     DOI： 10.1007/s12072-013-9493-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  19 in total

1.  Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

Authors:  Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; Antonio Craxi; Peter R Galle; Armando Santoro; Michel Beaugrand; Angelo Sangiovanni; Camillo Porta; Guido Gerken; Jorge A Marrero; Andrea Nadel; Michael Shan; Marius Moscovici; Dimitris Voliotis; Josep M Llovet
Journal:  J Hepatol       Date:  2012-06-19       Impact factor: 25.083

2.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

Review 3.  New progress of non-surgical treatments for hepatocellular carcinoma.

Authors:  Ji-Wen Cheng; Yi Lv
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

Review 4.  Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.

Authors:  Massimo Colombo; Jean-Luc Raoul; Riccardo Lencioni; Peter R Galle; Jessica Zucman-Rossi; Rafael Bañares; Daniel Seehofer; Peter Neuhaus; Philip Johnson
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-06       Impact factor: 2.566

5.  Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-alpha-mediated inhibition of hepatocellular carcinoma cell proliferation.

Authors:  K Murakami; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Cancer Lett       Date:  2000-04-03       Impact factor: 8.679

6.  Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.

Authors:  Makoto Iwata; Yuko Eshima; Hiroyuki Kagechika
Journal:  Int Immunol       Date:  2003-08       Impact factor: 4.823

Review 7.  Tamibarotene.

Authors:  Ishido Miwako; Hiroyuki Kagechika
Journal:  Drugs Today (Barc)       Date:  2007-08       Impact factor: 2.245

8.  BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.

Authors:  Andrew R Hallahan; Joel I Pritchard; Roshantha A S Chandraratna; Richard G Ellenbogen; J Russel Geyer; Ryan P Overland; Andrew D Strand; Stephen J Tapscott; James M Olson
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

9.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

10.  An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.

Authors:  Fumihiko Kanai; Shuntaro Obi; Shigetoshi Fujiyama; Shuichiro Shiina; Hideyuki Tamai; Hitoshi Mochizuki; Yukihiro Koike; Jun Imamura; Takayoshi Yamaguchi; Isamu Saida; Osamu Yokosuka; Masao Omata
Journal:  Hepatol Int       Date:  2013-07-25       Impact factor: 9.029
View more
  2 in total

1.  Inclusion complex of tamibarotene with hydroxypropyl-β-cyclodextrin: Preparation, characterization, in-vitro and in-vivo evaluation.

Authors:  Ying Yang; Jinhua Gao; Xiaoyu Ma; Guihua Huang
Journal:  Asian J Pharm Sci       Date:  2016-09-21       Impact factor: 6.598

2.  Laminarin from Seaweed (Laminaria japonica) Inhibits Hepatocellular Carcinoma Through Upregulating Senescence Marker Protein-30.

Authors:  Lin Tian; Chun-Mei Li; Yan-Fei Li; Tian-Ming Huang; Nai-Xia Chao; Guo-Rong Luo; Fa-Rong Mo
Journal:  Cancer Biother Radiopharm       Date:  2020-03-10       Impact factor: 3.099
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.